Dr.reddy's Laboratories Ltd — Rivaroxaban Exporter Profile
Indian Pharmaceutical Exporter · #2 for Rivaroxaban · $5.2M export value · DGFT Verified
Dr.reddy's Laboratories Ltd is the #2 Indian exporter of Rivaroxaban with $5.2M in export value and 131 verified shipments. Dr.reddy's Laboratories Ltd holds a 9.9% market share in Rivaroxaban exports across 12 countries.
Dr.reddy's Laboratories Ltd — Rivaroxaban Export Profile: Buyers & Destinations

Where Does Dr.reddy's Laboratories Ltd Export Rivaroxaban?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MALTA | $1.1M | 63 | 33.4% |
| BRAZIL | $690.9K | 20 | 21.3% |
| UNITED KINGDOM | $427.9K | 12 | 13.2% |
| VIETNAM | $263.4K | 8 | 8.1% |
| GERMANY | $222.1K | 6 | 6.8% |
| ITALY | $200.0K | 4 | 6.2% |
| VIETNAM, DEMOCRATIC REP. OF | $121.2K | 5 | 3.7% |
| SAUDI ARABIA | $109.7K | 3 | 3.4% |
| COLOMBIA | $64.7K | 2 | 2.0% |
| BELARUS | $34.2K | 8 | 1.1% |
Dr.reddy's Laboratories Ltd exports Rivaroxaban to 13 countries. The largest destination is MALTA accounting for 33.4% of Dr.reddy's Laboratories Ltd's Rivaroxaban shipments, followed by BRAZIL (21.3%) and UNITED KINGDOM (13.2%). These destinations reflect Dr.reddy's Laboratories Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Rivaroxaban from Dr.reddy's Laboratories Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| PHARMADOX HEALTHCARE LTD | MALTA | $1.1M | 63 |
| BIOLAB FARMA GENERICO | BRAZIL | $490.9K | 15 |
| TECHCOMBANK CHO LON BRANCH | VIETNAM, DEMOCRATIC REP. OF | $337.3K | 11 |
| MOVIANTO UK LTD | UNITED KINGDOM | $276.1K | 8 |
| DEPO PACK SNC | ITALY | $200.0K | 4 |
| ACHE LABORATORIOS FARMACEUTICOS S.A | BRAZIL | $150.0K | 3 |
| NEXTPHARMA LOGISTICS GMBH | GERMANY | $122.1K | 4 |
| MOVIANTO UK LIMITED | UNITED KINGDOM | $100.0K | 2 |
| SUDAIR PHARMA, UNIT 6 | SAUDI ARABIA | $80.6K | 2 |
| DR.REDDY'S LABORATORIES SAS | COLOMBIA | $64.7K | 2 |
Dr.reddy's Laboratories Ltd supplies Rivaroxaban to 28 buyers globally. The largest buyer is PHARMADOX HEALTHCARE LTD (MALTA), followed by BIOLAB FARMA GENERICO (BRAZIL) and TECHCOMBANK CHO LON BRANCH (VIETNAM, DEMOCRATIC REP. OF). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Rivaroxaban Export Value and How Much Does Dr.reddy's Laboratories Ltd Contribute?
India exported $36.7M worth of Rivaroxaban through 5,361 shipments from 221 suppliers to 115 countries, serving 497 buyers globally. Dr.reddy's Laboratories Ltd contributes $5.2M to this total, accounting for 9.9% of India's Rivaroxaban exports. Dr.reddy's Laboratories Ltd ships Rivaroxaban to 13 countries through 28 buyers.
What Is the Average Shipment Value for Dr.reddy's Laboratories Ltd's Rivaroxaban Exports?
Dr.reddy's Laboratories Ltd's average Rivaroxaban shipment value is $39.6K per consignment, based on 131 shipments totaling $5.2M. The largest destination is MALTA (33.4% of Dr.reddy's Laboratories Ltd's Rivaroxaban exports).
How Does Dr.reddy's Laboratories Ltd Compare to Other Indian Rivaroxaban Exporters?
Dr.reddy's Laboratories Ltd ranks #2 among 221 Indian Rivaroxaban exporters with a 9.9% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($12.8M), DR.REDDY'S LABORATORIES LTD ($5.2M), ZENTIVA PRIVATE LIMITED ($3.2M). Dr.reddy's Laboratories Ltd processed 131 shipments to 12 destination countries.
What Rivaroxaban Formulations Does Dr.reddy's Laboratories Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| RIVAROXABAN BETA 15 MG FILMTABLETTEN 98(23346X98S=2287908 NOS)NOS | $150.0K | 3 |
| RIVAROXABAN BETA 20 MG FILMTABLETTEN 98(34824X98S=3412752 NOS)NOS | $150.0K | 3 |
| RIVAROXABAN REDDY 20MG 28S TAB UK (81950X28S=2294600 NOS)NOS | $150.0K | 3 |
| RIVAROXABAN REDDY 15MG 28S TAB UK (32195X28S=901460 NOS)NOS | $116.3K | 3 |
| RIVAROXABAN BETA 10 MG FILMTABLETTEN 100(11340X100S=1134000 NOS)NOS | $109.0K | 3 |
| RIVAROXABANA 20MG TAB 28S | $100.0K | 2 |
| RIVAXORED (RIVAROXABAN 10MG) (4420 X 10S | $100.0K | 2 |
| RIVAROXABANA 10MG TAB 30 S (15936 X30 = | $100.0K | 2 |
| RIVAROXABAN BETA 20 MG FILMTABLETTEN 98(10032X98S=983136 NOS)NOS | $86.4K | 3 |
| RIVAROXABANA 10MG TAB 30S | $80.9K | 4 |
Dr.reddy's Laboratories Ltd exports 86 distinct Rivaroxaban formulations including tablets, capsules, syrups, and combination drugs. The top formulation is RIVAROXABAN BETA 15 MG FILMTABLETTEN 98(23346X98S=2287908 NO with 3 shipments worth $150.0K.
Regulatory Requirements: Exporting Rivaroxaban to Key Markets
What Dr.reddy's Laboratories Ltd must comply with to export Rivaroxaban to its top destination countries
Brazil — ANVISA
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Dr.reddy's Laboratories Ltd Compare to Nearest Rivaroxaban Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED | $12.8M | 257 | 11 | $50.0K |
| 2 | DR.REDDY'S LABORATORIES LTD ★ | $5.2M | 131 | 12 | $39.6K |
| 3 | ZENTIVA PRIVATE LIMITED | $3.2M | 148 | 2 | $21.5K |
| 5 | MICRO LABS LIMITED | $2.4M | 141 | 20 | $16.9K |
Dr.reddy's Laboratories Ltd ranks #2 among 221 Indian Rivaroxaban exporters. Average shipment value of $39.6K compared to the market average of $166.0K. The closest competitors by value are MYLAN LABORATORIES LIMITED and ZENTIVA PRIVATE LIMITED.
Which Indian Ports Ship Rivaroxaban Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,144 | 21.3% |
| DELHI AIR CARGO ACC (INDEL4) | 985 | 18.4% |
| DELHI AIR | 659 | 12.3% |
| SAHAR AIR CARGO ACC (INBOM4) | 635 | 11.8% |
| Bombay Air | 197 | 3.7% |
| NHAVA SHEVA SEA (INNSA1) | 164 | 3.1% |
| Delhi Air | 133 | 2.5% |
| HYDERABAD AIR | 110 | 2.1% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Rivaroxaban — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Rivaroxaban shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Dr.reddy's Laboratories Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 138 individual customs records matching Dr.reddy's Laboratories Ltd exporting Rivaroxaban, covering 86 formulations to 13 countries via 28 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 115+ countries, 497+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Rivaroxaban Export Data from Dr.reddy's Laboratories Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Dr.reddy's Laboratories Ltd's Rivaroxaban exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Dr.reddy's Laboratories Ltd
Company Profile
0 products · $0 total trade · 0 categories
Rivaroxaban Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Dr.reddy's Laboratories Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Rivaroxaban. For current shipment-level data, contact TransData Nexus.